Sun Pharmaceutical's Open Interest Surges 11.49% to 82,519 Contracts

Sun Pharmaceutical Industries Ltd (symbol: SUNPHARMA) has experienced a notable increase in open interest today, reflecting heightened activity in the derivatives market. The latest open interest stands at 82,519 contracts, up from the previous figure of 74,013, marking a change of 8,506 contracts or an 11.49% increase. The trading volume for the day reached 45,964 contracts, indicating robust participation. In terms of price performance, Sun Pharma has been trading in a narrow range of Rs 14.9 and has seen a slight decline of 0.37% in its stock price today. Over the past two days, the stock has recorded a total drop of 1.1%. Despite this recent downturn, Sun Pharma is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong underlying trend. The company's market capitalization is approximately Rs 4,07,191.14 crore, positioning it firmly within the large-cap segment of the Pharmaceuticals & Biotechnology industry. With a delivery volume of 12.73 lakh on October 30, which is 1.56% higher than the 5-day average, the stock demonstrates sufficient liquidity for trading activities. Overall, the increase in open interest alongside the current trading metrics highlights a significant moment for Sun Pharmaceutical Industries in the market.